ECP 2023 Final Programme

Monday, 11 Sept Scientific Programme a Monday 41 ECP 2023 Dublin 003 10:30–10:52 Artificial intelligence and digital pathology: new scenarios for thyroid pathology? Catarina Eloy, Portugal 004 10:52–11:15 Genotype-phenotype correlations in adrenal cortical neoplasms Marco Volante, Italy 005 11:15–11:37 Neuroendocrine tumours of the appendix: recent insights and clinical implications Aurel Perren, Switzerland 006 11:37–12:00 Beyond proliferation grade: prognostic biomarkers in digestive neuroendocrine tumours Guido Rindi, Italy LC-04 Long Course 08:30–12:00 Liffey Hall 1 Dermatopathology Soft Tissue and Bone Pathology Joint Long Course: When mesenchymal tumours come up to the skin Chairs: Fernanda Amary, United Kingdom Bostjan Luzar, Slovenia 001 08:30–09:00 Cutaneous spindle cell tumours with kinase fusions – emerging entity Albert Suurmeijer, The Netherlands 002 09:00–09:30 Update on cutaneous adipocytic tumours David Creytens, Belgium 003 10:30–10:52 Update on cutaneous soft tissue tumours with round cell morphology Zlatko Marusic, Croatia 004 10:52–11:15 Intermediate vascular tumours or low grade angiosarcoma? Julie C. Fanburg-Smith, USA 005 11:15–11:37 Epithelioid mesenchymal malignancies Eva Wardelmann, Germany 006 11:37–12:00 Cytokeratin-expressing non epithelial tumours of the skin Adrienne Flanagan, United Kingdom OFP-04 Joint Oral Free Paper Session 08:30–12:00 Ecocem Nephropathology Uropathology Chairs: Felix Bremmer, Germany Dejan Dobi, Hungary 001 08:30–08:40 For those who like to see numbers in pathology reports when histological grading is blurry... Ezgi Dicle Serbes, Turkey M. Karaburun, K. Obaid, M. Babayigit, M. Gogus, S. Baltaci, E. Suer, S. Kiremitci, D. Enneli 002 08:40–08:50 Molecular subtyping of upper urinary tract urothelial carcinomas with surrogate immunohistochemical markers Ezgi Dicle Serbes, Turkey M. Babayigit, S. Sevim, E. Suer, M. Gogus, S. Kiremitci, D. Enneli 003 08:50–09:00 Does GATA3 expression contribute to diag- nosis in renal tumours with eosinophilic/ oncocytic features? Ceren Utku, Turkey B. Sarsik Kumbaraci, B. Yaman, M. Kalemci, S. Sen 004 09:00–09:10 Investigating the prognostic value of invasive cribriform gland size and percentage in grade group 2 and grade group 3 prostate adenocarcinoma Emel Tekin, Turkey N. Şeker, A. Ozen, M. Açıkalın, C. Can, E. Çolak 005 09:10–09:20 Intraepithelial CD8+ cytotoxic T-cells are the main component of the immune tumour microenvironment that drive prognosis in muscle-invasive bladder cancer Niclas Blessin, Germany N. Debatin, E. Bady, T. Mandelkow, H. Samtleben, D. Horst, A. Marx, M. Fisch, M. Slojewski, T. Ecke, S. Koch, N. Adamini, G. Sauter, T. Schlomm, H. Zecha